Your trusted source for investing success

Tag: AveXis

5 February IPOs on the NASDAQ

5 February IPOs on the NASDAQ

This month, investors can expect some new blood to enter the life science market, with five companies — Editas Medicine, BeiGene, Protestasis Therapeutics, AveXis, Cancer Prevention Pharmaceuticals— listing on the NASDAQ.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
4 Gene Therapy Stocks to Watch in 2017

URL: https://investingnews.com/daily/life-science-investing/genetics-investing/4-gene-therapy-stocks-to-watch-2017/